Prenetics Global Limited - Class A Ordinary Share (PRE)
13.08
+0.00 (0.00%)
NASDAQ · Last Trade: Oct 28th, 7:12 AM EDT
Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · October 27, 2025
Via Benzinga · October 27, 2025
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · October 27, 2025

Prenetics Global just reported results for the first quarter of 2024.
Via InvestorPlace · June 18, 2024
Via Benzinga · October 27, 2025
Via Benzinga · October 24, 2025
Prenetics Global Limited (PRE) completes $20 million BTC purchase, aims to become one of the largest healthcare corporate BTC holders globally.
Via Benzinga · June 18, 2025
Via Benzinga · June 13, 2025
Via Benzinga · June 12, 2025
Via Benzinga · May 23, 2025

Via Benzinga · October 15, 2024

Via Benzinga · October 4, 2024

Prenetics Global (NASDAQ: PRE): Bending Biotech with Beckham
Via News Direct · July 12, 2024

Prenetics announces David Beckham as a strategic investor and co-founding partner of IM8, a new health and wellness brand. IM8 will focus on consumer health products.
Via Benzinga · July 11, 2024

Prenetics Global Limited: Genomic Innovations Making Waves in Cancer Care”
Via News Direct · June 20, 2024

Via Benzinga · April 29, 2024

Via Benzinga · April 24, 2024

Via Benzinga · April 24, 2024

PRE stock results show that Prenetics Global beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · April 1, 2024

Via Benzinga · March 26, 2024



